Incyte (INCY) Capital Leases (2019 - 2026)
Incyte (INCY) posted Capital Leases of $29.4 million for Q1 2026, down 2.6% on a QoQ basis from $30.2 million in Q4 2025, and down 9.89% year-over-year from $32.6 million in Q1 2025.
Incyte (INCY) Capital Leases (2019 - 2026) Analysis & Trends
Incyte's Capital Leases history runs 8 years deep, the most recent figure standing at $29.4 million for Q1 2026.
- Quarterly Capital Leases fell 9.89% year-over-year to $29.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.4 million (down 9.89% YoY) and the FY2025 annual result came in at $30.2 million, down 9.97% from the prior year.
- Capital Leases was $29.4 million for Q1 2026 at Incyte, down from $30.2 million in the prior quarter.
- Across five years, Capital Leases topped out at $33.5 million in Q4 2024 and bottomed at $28.2 million in Q3 2024.
- A 5-year average of $30.3 million and a median of $30.1 million in 2022 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2024 — Capital Leases rose 15.02% — and 2025, when it retreated 9.97%.
- Incyte's Capital Leases stood at $30.1 million in 2022, then declined by 3.06% to $29.2 million in 2023, then rose by 15.02% to $33.5 million in 2024, then declined by 9.97% to $30.2 million in 2025, then fell by 2.6% to $29.4 million in 2026.
- Business Quant data shows INCY's Capital Leases at $29.4 million in Q1 2026, $30.2 million in Q4 2025, and $30.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.41 Mn |
| Dec 31, 2025 | 30.20 Mn |
| Sep 30, 2025 | 30.88 Mn |
| Jun 30, 2025 | 31.76 Mn |
| Mar 31, 2025 | 32.64 Mn |
| Dec 31, 2024 | 33.54 Mn |
| Sep 30, 2024 | 28.22 Mn |
| Jun 30, 2024 | 28.75 Mn |
| Mar 31, 2024 | 28.93 Mn |
| Dec 31, 2023 | 29.16 Mn |
| Sep 30, 2023 | 28.86 Mn |
| Jun 30, 2023 | 29.49 Mn |
| Mar 31, 2023 | 29.70 Mn |
| Dec 31, 2022 | 30.08 Mn |
| Sep 30, 2022 | 30.48 Mn |
| Jun 30, 2022 | 31.16 Mn |
| Mar 31, 2022 | 31.39 Mn |
| Dec 31, 2021 | 31.63 Mn |
| Sep 30, 2021 | 31.38 Mn |
| Jun 30, 2021 | 31.84 Mn |